Sector: Health Care.Industry: Pharmaceuticals
Cormedix Inc is a biopharmaceutical company which focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. The Neutrolin product is designed to target unmet medical need.
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| CRMD | Cormedix | 0.76% | 301.5M |
Cormedix Company Questions & Answers
Q
How do I buy Cormedix (CRMD) stock?
A
You can purchase shares of Cormedix (NASDAQ: CRMD) through any online brokerage.
Q
Who are Cormedix's (CRMD) main competitors?
A
Other companies in Cormedix’s space includes: BioDelivery Sciences Intl (NASDAQ:BDSI), WAVE Life Sciences (NASDAQ:WVE) and Xeris Pharmaceuticals (NASDAQ:XERS).
Q
What is the target price for Cormedix?
A
The latest price target for Cormedix (NASDAQ: CRMD) was reported by Needham on 2021-02-17. The analyst firm set a price target for 31.00 expecting CRMD to rise to within 12 months (a possible 290.92% upside). 1 analyst firms have reported ratings in the last year.
Q
How much is Cormedix (CRMD) stock ?
A
The stock price for Cormedix (NASDAQ: CRMD) is $7.93 last updated Today at 8:00:02 PM.
Q
When is the next Cormedix (CRMD) dividend?
A
There are no upcoming dividends for Cormedix.
Q
When is Cormedix (NASDAQ:CRMD) reporting earnings?
A
There are no earnings for Cormedix
Q
When is the upcoming split for CRMD?
A
There is no upcoming split for Cormedix.